Article Outline: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
(New page: ==Abstract== *Background **Staphylococcus aureus - human pathogen. Treatments are needed. Antimicrobial peptides potential antibiotic to MRSA. ***Such as Renalexin - fights against gram p...) |
No edit summary |
||
Line 13: | Line 13: | ||
==Background== | ==Background== | ||
*MRSA - major cause of mortality and mobility. Resistant strains to treatments continue to emerge. Global problem --> community-associated MRSA. | |||
**Prevention and treatment is needed! | |||
*Antimicrobial peptides (AMPs) - novel antibiotic --> could be developed to combat bacteria that is resistant (such as MRSA). | |||
**Produces by all living creatures for defenses -- 880 have been described. | |||
*Renalexin | |||
**20 a.a. peptide (cationic) | |||
**Possesses single intramolecular dispulphide bond --> forming heptapeptide ring at carboxyl terminus. | |||
**Displays strong activity against Staphylococcus aureus (Gram-positive bacteria). | |||
**Offers potential against staphylococcal infections (including MRSA). | |||
*Need to understand antimicrobial action mechanisms to develop strategies. | |||
*Antimicrobial inhibitory action can by studied by transcriptome and proteome profiling. | |||
*Generation of protein and mRNA in response to antimicrobial stress are shown in certain cell functions and provide stress type imposed. | |||
*Modeled pathway relationships for 95% of S. aureus MRSA-252 genes by integrating proteome and transcriptome profiling of bacteria that was drug-exposed w/ high-confidence functional association network. | |||
**Approach showed 22 virulence factors and killing mechs. for renalexin along with cell wall effects. | |||
**Evidence of VraRS two-component system in cationic peptide resistance. | |||
*Drug target candidate - FtsH. Role of PhoU-mediated persister formation in S. aureus drug tolerance. | |||
==Results and Discussion== | |||
Revision as of 15:32, 9 November 2011
Abstract
- Background
- Staphylococcus aureus - human pathogen. Treatments are needed. Antimicrobial peptides potential antibiotic to MRSA.
- Such as Renalexin - fights against gram positive bacteria, S. aureus in particular.
- Study of drug resistance and mode of action is important.
- Staphylococcus aureus - human pathogen. Treatments are needed. Antimicrobial peptides potential antibiotic to MRSA.
- Results
- Bayesian logistic regression - allows identification of renalexin response modules from MRSA-252 preteome and transcriptome profiling.
- Relaxin displayed killing mechanisms & cell wall activity.
- Gene disruption and osmotic fragility experiments supported cell wall effects.
- 22 Virulence factors inferred --> VraRS two-component system & PhoU-mediated persister formation --> MRSA tolerance to cationic antimicrobial peptides.
- Conclusions
- Integrative approach to study drug resistance and their mode of action. Finds lead to development of trategies against Staphylococcus aureus (MRSA in particular)
Background
- MRSA - major cause of mortality and mobility. Resistant strains to treatments continue to emerge. Global problem --> community-associated MRSA.
- Prevention and treatment is needed!
- Antimicrobial peptides (AMPs) - novel antibiotic --> could be developed to combat bacteria that is resistant (such as MRSA).
- Produces by all living creatures for defenses -- 880 have been described.
- Renalexin
- 20 a.a. peptide (cationic)
- Possesses single intramolecular dispulphide bond --> forming heptapeptide ring at carboxyl terminus.
- Displays strong activity against Staphylococcus aureus (Gram-positive bacteria).
- Offers potential against staphylococcal infections (including MRSA).
- Need to understand antimicrobial action mechanisms to develop strategies.
- Antimicrobial inhibitory action can by studied by transcriptome and proteome profiling.
- Generation of protein and mRNA in response to antimicrobial stress are shown in certain cell functions and provide stress type imposed.
- Modeled pathway relationships for 95% of S. aureus MRSA-252 genes by integrating proteome and transcriptome profiling of bacteria that was drug-exposed w/ high-confidence functional association network.
- Approach showed 22 virulence factors and killing mechs. for renalexin along with cell wall effects.
- Evidence of VraRS two-component system in cationic peptide resistance.
- Drug target candidate - FtsH. Role of PhoU-mediated persister formation in S. aureus drug tolerance.
Results and Discussion
Links
- Alex A. Cardenas
- Week 10 Assignment
- Alex A. Cardenas Week 2
- Alex A. Cardenas Week 3
- Alex A. Cardenas Week 4
- Alex A. Cardenas Week 5
- Alex A. Cardenas Week 6
- Alex A. Cardenas Week 7
- Alex A. Cardenas Week 8
- Alex A. Cardenas Week 9
- Alex A. Cardenas Week 10
- Alex A. Cardenas Week 11
- Alex A. Cardenas Week 12
- Alex A. Cardenas Week 13
- Alex A. Cardenas Week 14
- Class Journal Week 1
- Class Journal Week 2
- Class Journal Week 3
- Class Journal Week 5
- Class Journal Week 6
- Class Journal Week 7
- Class Journal Week 8
- Class Journal Week 9
- Class Journal Week 10
- Class Journal Week 11
- Class Journal Week 12
- Class Journal Week 13
- Class Journal Week 14